Haemonetics

Haemonetics agreed to acquire Cardiva Medical, a manufacturer of vascular closure systems, for $475 million upfront plus up to $35 million in contingent consideration, expected to close in Q1 2021.

Haemonetics agreed to sell its wholly owned subsidiary Inlog Holdings France, which develops blood bank and hospital software, to French private equity firm Abénex.

Haemonetics and GVS will enter a long-term supply and development agreement granting GVS exclusive rights to manufacture and supply blood filters currently produced at the Fajardo facility for Haemonetics.

Haemonetics agreed to sell its Fajardo, Puerto Rico manufacturing operations to GVS, S.p.A. GVS will acquire manufacturing equipment, inventory and a sublease, while Haemonetics retains IP rights to blood filters. The parties will also enter a long-term supply agreement. Closing expected in Q2 2020.